null

SMILES: C[C@@H](CO)NCc1cnc2c(Nc3cccc(c3C)-c3cccc(-c4nc5cc(CN6CC[C@](C)(C6)C(O)=O)cc(C#N)c5o4)c3C)nc(C)nc2c1

InChI Key: InChIKey=ALZVBCBIJOBHLG-PRAKJKJKSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 446461   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] (Homo sapiens (Human))	BDBM446461 ((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...) Show SMILES C[C@@H](CO)NCc1cnc2c(Nc3cccc(c3C)-c3cccc(-c4nc5cc(CN6CC[C@](C)(C6)C(O)=O)cc(C#N)c5o4)c3C)nc(C)nc2c1 |r| Show InChI InChI=1S/C41H42N8O4/c1-23(21-50)43-18-28-16-34-36(44-19-28)38(46-26(4)45-34)47-33-11-7-9-31(25(33)3)30-8-6-10-32(24(30)2)39-48-35-15-27(14-29(17-42)37(35)53-39)20-49-13-12-41(5,22-49)40(51)52/h6-11,14-16,19,23,43,50H,12-13,18,20-22H2,1-5H3,(H,51,52)(H,45,46,47)/t23-,41+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Incyte Corporation US Patent					Assay Description The assays were conducted in a standard black 384-well polystyrene plate with a final volume of 20 μL. Inhibitors were first serially diluted in...				US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC
					More data for this Ligand-Target Pair
Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] (Homo sapiens (Human))	BDBM446461 ((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...) Show SMILES C[C@@H](CO)NCc1cnc2c(Nc3cccc(c3C)-c3cccc(-c4nc5cc(CN6CC[C@](C)(C6)C(O)=O)cc(C#N)c5o4)c3C)nc(C)nc2c1 |r| Show InChI InChI=1S/C41H42N8O4/c1-23(21-50)43-18-28-16-34-36(44-19-28)38(46-26(4)45-34)47-33-11-7-9-31(25(33)3)30-8-6-10-32(24(30)2)39-48-35-15-27(14-29(17-42)37(35)53-39)20-49-13-12-41(5,22-49)40(51)52/h6-11,14-16,19,23,43,50H,12-13,18,20-22H2,1-5H3,(H,51,52)(H,45,46,47)/t23-,41+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description The assays were conducted in a standard black 384-well polystyrene plate with a final volume of 20 μL. Inhibitors were first serially diluted in...				Citation and Details BindingDB Entry DOI: 10.7270/Q2VT1W8C
					More data for this Ligand-Target Pair
Nuclear factor NF-kappa-B p105 subunit (Homo sapiens (Human))	BDBM446461 ((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...) Show SMILES C[C@@H](CO)NCc1cnc2c(Nc3cccc(c3C)-c3cccc(-c4nc5cc(CN6CC[C@](C)(C6)C(O)=O)cc(C#N)c5o4)c3C)nc(C)nc2c1 |r| Show InChI InChI=1S/C41H42N8O4/c1-23(21-50)43-18-28-16-34-36(44-19-28)38(46-26(4)45-34)47-33-11-7-9-31(25(33)3)30-8-6-10-32(24(30)2)39-48-35-15-27(14-29(17-42)37(35)53-39)20-49-13-12-41(5,22-49)40(51)52/h6-11,14-16,19,23,43,50H,12-13,18,20-22H2,1-5H3,(H,51,52)(H,45,46,47)/t23-,41+/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
Incyte Corporation US Patent					Assay Description PD-L1 aAPC/CHO-Klcells (Promega) were maintained in F-12 medium with addition of 10% FBS, 200 μg/ml Hygromycin B, 250 μg/ml Geneticin (G418...				US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC
					More data for this Ligand-Target Pair
Tyrosine-protein phosphatase non-receptor type 11 (Homo sapiens (Human))	BDBM446461 ((R)-1-((7-cyano-2-(3′-(7-(((S)-1-hydroxyprop...) Show SMILES C[C@@H](CO)NCc1cnc2c(Nc3cccc(c3C)-c3cccc(-c4nc5cc(CN6CC[C@](C)(C6)C(O)=O)cc(C#N)c5o4)c3C)nc(C)nc2c1 |r| Show InChI InChI=1S/C41H42N8O4/c1-23(21-50)43-18-28-16-34-36(44-19-28)38(46-26(4)45-34)47-33-11-7-9-31(25(33)3)30-8-6-10-32(24(30)2)39-48-35-15-27(14-29(17-42)37(35)53-39)20-49-13-12-41(5,22-49)40(51)52/h6-11,14-16,19,23,43,50H,12-13,18,20-22H2,1-5H3,(H,51,52)(H,45,46,47)/t23-,41+/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Incyte Corporation US Patent					Assay Description U2OS/PD-L1 cells (DiscoveRx Corporation) were maintained in McCoy's 5A medium with addition of 10% FBS, 0.25 μg/ml Puromycin. After removing...				US Patent US10669271 (2020) BindingDB Entry DOI: 10.7270/Q2MG7SJC
					More data for this Ligand-Target Pair